FDA recall D-0793-2017

GlaxoSmithKline, LLC · Class II · drug

Product

Ventolin HFA (albuterol sulfate) Inhalation, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0682-20.

Reason for recall

Defective Delivery System: Elevated number of units with out of specification results for leak rate

Distribution

Nationwide in the US and Puerto Rico

Key facts

Status
Ongoing
Initiation date
2017-05-16
Report date
2017-05-31
Voluntary/Mandated
Voluntary: Firm initiated
Location
Zebulon, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0793-2017